期刊
LANCET
卷 389, 期 10070, 页码 736-747出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(16)30970-9
关键词
-
资金
- Australia (NHMRC)
- Brazil (FAPESP)
- Netherlands (ZonMW)
- Australia's National Health and Medical Research Council
- Australian Research Council
- Arthritis Australia
- NSW WorkCover
- NHMRC
- GlaxoSmithKline
- UK National Institute for Health Research
- HTA Project [11/31/01]
- ARC
- ZonMW in the Netherlands
- PCORI in the USA
- National Institute for Health Research [NF-SI-0616-10043, NF-SI-0512-10103] Funding Source: researchfish
Non-specific low back pain affects people of all ages and is a leading contributor to disease burden worldwide. Management guidelines endorse triage to identify the rare cases of low back pain that are caused by medically serious pathology, and so require diagnostic work-up or specialist referral, or both. Because non-specific low back pain does not have a known pathoanatomical cause, treatment focuses on reducing pain and its consequences. Management consists of education and reassurance, analgesic medicines, non-pharmacological therapies, and timely review. The clinical course of low back pain is often favourable, thus many patients require little if any formal medical care. Two treatment strategies are currently used, a stepped approach beginning with more simple care that is progressed if the patient does not respond, and the use of simple risk prediction methods to individualise the amount and type of care provided. The overuse of imaging, opioids, and surgery remains a widespread problem.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据